Frequency of TSC1 and TSC2 mutations in American, British, Polish and Taiwanese populations

Molecular Medicine Reports

Volumn 8, Issue 3, 2013, Pages 909-913

  Jóźwiak, JarosŁaw ^a   Sontowska, Iwona ^a   PŁoski, RafaŁ ^b  

^a MEDICAL UNIVERSITY OF WARSAW   (Poland)

^b MEDICAL UNIVERSITY OF WARSAW   (Poland)

Author keywords

Mutation frequency; Tuberous sclerosis; Tuberous sclerosis complex 1; Tuberous sclerosis complex 2

Indexed keywords

ARTICLE; GENE; GENE MUTATION; NUCLEIC ACID BASE SUBSTITUTION; NUCLEOTIDE SEQUENCE; POLAND; RACE DIFFERENCE; STATISTICAL ANALYSIS; TAIWAN; TSC1 GENE; TSC2 GENE; TUBEROUS SCLEROSIS; UNITED KINGDOM; UNITED STATES;

ALLELES; ANALYSIS OF VARIANCE; ASIAN CONTINENTAL ANCESTRY GROUP; COHORT STUDIES; EUROPEAN CONTINENTAL ANCESTRY GROUP; GENE FREQUENCY; GENOTYPE; GREAT BRITAIN; HUMANS; POLAND; POLYMORPHISM, SINGLE NUCLEOTIDE; TAIWAN; TUBEROUS SCLEROSIS; TUMOR SUPPRESSOR PROTEINS; UNITED STATES;

EID: 84881123154     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr.2013.1583     Document Type: Article

References (18)

1. Jones AC, Daniells CE, Snell RG, Tachataki M, Idziaszczyk SA, Krawczak M, Sampson JR and Cheadle JP: Molecular genetic and phenotypic analysis reveals differences between TSC1 and TSC2 associated familial and sporadic tuberous sclerosis. Hum Mol Genet 6: 2155-2161, 1997.
2. Jones AC, Shyamsundar MM, Thomas MW, Maynard J, Idziaszczyk S, Tomkins S, Sampson JR and Cheadle JP: Comprehensive mutation analysis of TSC1 and TSC2 - and phenotypic correlations in 150 families with tuberous sclerosis. Am J Hum Genet 64: 1305-1315, 1999.
3. Niida Y, Lawrence-Smith N, Banwell A, Hammer E, Lewis J, Beauchamp RL, Sims K, Ramesh V and Ozelius L: Analysis of both TSC1 and TSC2 for germline mutations in 126 unrelated patients with tuberous sclerosis. Hum Mutat 14: 412-422, 1999.
4. Dabora SL, Jozwiak S, Franz DN, Roberts PS, Nieto A, Chung J, Choy YS, Reeve MP, Thiele E, Egelhoff JC, Kasprzyk-Obara J, Domanska-Pakiela D and Kwiatkowski DJ: Mutational analysis in a cohort of 224 tuberous sclerosis patients indicates increased severity of TSC2, compared with TSC1, disease in multiple organs. Am J Hum Genet 68: 64-80, 2001.
5. Hung CC, Su YN, Chien SC, Liou HH, Chen CC, Chen PC, Hsieh CJ, Chen CP, Lee WT, Lin WL and Lee CN: Molecular and clinical analyses of 84 patients with tuberous sclerosis complex. BMC Med Genet 7: 72, 2006.
6. Roach ES, Gomez MR and Northrup H: Tuberous sclerosis complex consensus conference: revised clinical diagnostic criteria. J Child Neurol 13: 624-628, 1998.
7. Gomez MR: Phenotypes of the tuberous sclerosis complex with a revision of diagnostic criteria. Ann N Y Acad Sci 615: 1-7, 1991.
8. Roach ES, Smith M, Huttenlocher P, Bhat M, Alcorn D and Hawley L: Diagnostic criteria: tuberous sclerosis complex. Report of the Diagnostic Criteria Committee of the National Tuberous Sclerosis Association. J Child Neurol 7: 221-224, 1992.
9. Eng C, Brody LC, Wagner TM, Devilee P, Vijg J, Szabo C, Tavtigian SV, Nathanson KL, Ostrander E and Frank TS; Steering Committee of the Breast Cancer Information Core (BIC) Consortium: Interpreting epidemiological research: blinded comparison of methods used to estimate the prevalence of inherited mutations in BRCA1. J Med Genet 38: 824-833, 2001.
10. Bunn CF, Lintott CJ, Scott RS and George PM: Comparison of SSCP and DHPLC for the detection of LDLR mutations in a New Zealand cohort. Hum Mutat 19: 311, 2002.
11. Pleasance ED, Stephens PJ, O'Meara S, McBride DJ, Meynert A, Jones D, Lin ML, Beare D, Lau KW, Greenman C, Varela I, Nik-Zainal S, Davies HR, Ordoñez GR, Mudie LJ, Latimer C, Edkins S, Stebbings L, Chen L, Jia M, Leroy C, Marshall J, Menzies A, Butler A, Teague JW, Mangion J, Sun YA, McLaughlin SF, Peckham HE, Tsung EF, Costa GL, Lee CC, Minna JD, Gazdar A, Birney E, Rhodes MD, McKernan KJ, Stratton MR, Futreal PA and Campbell PJ: A small-cell lung cancer genome with complex signatures of tobacco exposure. Nature 463: 184-190, 2010.
12. Daya-Grosjean L and Sarasin A: The role of UV induced lesions in skin carcinogenesis: an overview of oncogene and tumor suppressor gene modifications in xeroderma pigmentosum skin tumors. Mutat Res 571: 43-56, 2005.
13. Pleasance ED, Cheetham RK, Stephens PJ, McBride DJ, Humphray SJ, Greenman CD, Varela I, Lin ML, Ordóñez GR, Bignell GR, Ye K, Alipaz J, Bauer MJ, Beare D, Butler A, Carter RJ, Chen L, Cox AJ, Edkins S, Kokko-Gonzales PI, Gormley NA, Grocock RJ, Haudenschild CD, Hims MM, James T, Jia M, Kingsbury Z, Leroy C, Marshall J, Menzies A, Mudie LJ, Ning Z, Royce T, Schulz-Trieglaff OB, Spiridou A, Stebbings LA, Szajkowski L, Teague J, Williamson D, Chin L, Ross MT, Campbell PJ, Bentley DR, Futreal PA and Stratton MR: A comprehensive catalogue of somatic mutations from a human cancer genome. Nature 463: 191-196, 2010.
14. Pfeifer GP, You YH and Besaratinia A: Mutations induced by ultraviolet light. Mutat Res 571: 19-31, 2005.
15. Lobry JR: Asymmetric substitution patterns in the two DNA strands of bacteria. Mol Biol Evol 13: 660-665, 1996.
16. Tanaka M and Ozawa T: Strand asymmetry in human mitochondrial DNA mutations. Genomics 22: 327-335, 1994.
17. Green P, Ewing B, Miller W, Thomas PJ; NISC Comparative Sequencing Program, Green ED: Transcription-associated mutational asymmetry in mammalian evolution. Nat Genet 33: 514-517, 2003.
18. Mugal CF, von Grünberg HH and Peifer M: Transcription-induced mutational strand bias and its effect on substitution rates in human genes. Mol Biol Evol 26: 131-142, 2009.